HomeNewsIndiaBypassing theatrical release of films does not make any 'economical sense' for producers: PVR CMD Ajay Bijli

Bypassing theatrical release of films does not make any 'economical sense' for producers: PVR CMD Ajay Bijli

"Theatrical revenues still contribute more than 50 to 70 percent of the overall pie of any content and after that only you are able to monetise content better, if you go to other platforms. I think there is too much stake to give up on these revenues and plus if you go to OTT straight away, you let go off your overseas collection and music rights," said Bijli in an investor's call.

June 10, 2020 / 20:31 IST
Story continues below Advertisement

Multiplex chain PVR on Wednesday said bypassing theatrical release of films does not make any "economical sense" for producers as this medium contributes up to 70 percent of the overall earning and they lose revenue by releasing directly on OTT platforms.

Moreover, the film producers also have to lose overseas collections and music rights of their films by releasing them directly on the streaming services, said PVR Chairman and Managing Director Ajay Bijli.

Story continues below Advertisement

According to him, this is an exceptional period for the industry, when the screens are closed and hence some producers are deciding to release their movies directly on OTT (over-the-top) platforms.

"Theatrical revenues still contribute more than 50 to 70 percent of the overall pie of any content and after that only you are able to monetise content better, if you go to other platforms. I think there is too much stake to give up on these revenues and plus if you go to OTT straight away, you let go off your overseas collection and music rights," said Bijli in an investor's call.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show